Panoplia Laboratories
Panoplia Laboratories is a U.S.-based 501(c)(3) nonprofit that evaluates AI-driven biology and performs targeted wet‑lab research to inform biosecurity policy. The organization conducts empirical experiments (in vitro and in vivo), computational evaluations, and publishes results and analysis intended for the research and policy communities.
Industries
Nr. of Employees
small (1-50)
Products
Research Protocol Technician Study
A research study assessing if large-language models can assist individuals with minimal lab experience in performing biological tasks.
Research Protocol Technician Study
A research study assessing if large-language models can assist individuals with minimal lab experience in performing biological tasks.
Services
Experimental design and execution of focused laboratory studies addressing specific biosecurity risks (in vitro and in vivo).
Analysis and evaluation of AI outputs applied to biological design and experimental data analysis support.
Experimental design and execution of focused laboratory studies addressing specific biosecurity risks (in vitro and in vivo).
Analysis and evaluation of AI outputs applied to biological design and experimental data analysis support.
Expertise Areas
- Evaluation of AI-driven biology
- Wet‑lab biosecurity research
- Antimicrobial susceptibility testing
- Preclinical in vivo toxicity studies
Key Technologies
- Peptide conjugate immunogens
- Antibody immunoassays
- Antimicrobial susceptibility assays (in vitro)
- Mouse acute toxicity models
News & Updates
Summary of a preprint reporting in vitro testing of mirror‑image antibiotics across an 18‑strain bacterial panel, mouse single‑dose acute toxicity studies of mirror compounds, and peptide conjugate vaccine immunogenicity experiments.
Press coverage and discussion of the need for antivirals prepared for immediate deployment at the start of future pandemics.
Published a preprint describing experimental results on mirror antibiotics, mouse acute toxicity, and mirror peptide vaccine immunogenicity.
Work on antivirals and pandemic preparedness featured in Asimov press.
Summary of a preprint reporting in vitro testing of mirror‑image antibiotics across an 18‑strain bacterial panel, mouse single‑dose acute toxicity studies of mirror compounds, and peptide conjugate vaccine immunogenicity experiments.
Press coverage and discussion of the need for antivirals prepared for immediate deployment at the start of future pandemics.
Published a preprint describing experimental results on mirror antibiotics, mouse acute toxicity, and mirror peptide vaccine immunogenicity.
Work on antivirals and pandemic preparedness featured in Asimov press.